1. Home
  2. ORGS

ORGS

Orgenesis Inc.

Logo Orgenesis Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies.

Founded: 2008 Country:
United States
United States
Employees: 146 City: GERMANTOWN
Market Cap: 17.2M IPO Year: N/A
Target Price: $6.00 AVG Volume (30 days): 246.3K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 1.91 EPS Growth: 223.73
52 Week Low/High: $0.25 - $1.50 Next Earning Date: 05-08-2024
Revenue: $530,000 Revenue Growth: -98.53%
Revenue Growth (this year): 42.42% Revenue Growth (next year): 39.76%

Share on Social Networks: